Cell surface Cdc37 participates in extracellular HSP90 mediated cancer cell invasion

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  El Hamidieh, Avraam ^a   Grammatikakis, Nicholas ^b   Patsavoudi, Evangelia ^a,c  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c UNIVERSITY OF WEST ATTICA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN 37; EPIDERMAL GROWTH FACTOR RECEPTOR; HEAT SHOCK PROTEIN 90; MONOCLONAL ANTIBODY;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL MOTILITY; CELL SURFACE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CHAPERONINS; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION, NEOPLASTIC; HSP90 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASM INVASIVENESS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 84865104330     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042722     Document Type: Article

References (38)

1. Picard D, (2002) Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol Life Sci 59: 1640-1648.
2. Pratt WB, Toft DO, (2003) Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp Biol Med (Maywood) 228: 111-133.
3. Smith JR, Workman P, (2009) Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning. Cell Cycle 8: 362-372.
4. Siligardi G, Panaretou B, Meyer P, Singh S, Woolfson DN, et al. (2002) Regulation of Hsp90 ATPase activity by the co-chaperone Cdc37p/p50cdc37. J Biol Chem 277: 20151-20159.
5. Roe SM, Ali MM, Meyer P, Vaughan CK, Panaretou B, et al. (2004) The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37). Cell 116: 87-98.
6. Silverstein AM, Grammatikakis N, Cochran BH, Chinkers M, Pratt WB, (1998) p50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J Biol Chem 273: 20090-20095.
7. Kimura Y, Rutherford SL, Miyata Y, Yahara I, Freeman BC, et al. (1997) Cdc37 is a molecular chaperone with specific functions in signal transduction. Genes Dev 11: 1775-1785.
8. Stepanova L, Leng X, Harper JW, (1997) Analysis of mammalian Cdc37, a protein kinase targeting subunit of heat shock protein 90. Methods Enzymol 283: 220-229.
9. Grammatikakis N, Lin JH, Grammatikakis A, Tsichlis PN, Cochran BH, (1999) p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function. Mol Cell Biol 19: 1661-1672.
10. Stepanova L, Leng X, Parker SB, Harper JW, (1996) Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Genes Dev 10: 1491-1502.
11. Hartson SD, Irwin AD, Shao J, Scroggins BT, Volk L, et al. (2000) p50(cdc37) is a nonexclusive Hsp90 cohort which participates intimately in Hsp90-mediated folding of immature kinase molecules. Biochemistry 39: 7631-7644.
12. Bagatell R, Whitesell L, (2004) Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther 3: 1021-1030.
13. Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR, (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31: 164-172.
14. Neckers L, (2002) Hsp90 inhibitors as novel cancer chemotherapeutic agents. Trends Mol Med 8: S55-61.
15. Whitesell L, Lindquist SL, (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5: 761-772.
16. Pearl LH, (2005) Hsp90 and Cdc37 - a chaperone cancer conspiracy. Curr Opin Genet Dev 15: 55-61.
17. Gray PJ Jr, Prince T, Cheng J, Stevenson MA, Calderwood SK, (2008) Targeting the oncogene and kinome chaperone CDC37. Nat Rev Cancer 8: 491-495.
18. Thompson MA, Stumph J, Henrickson SE, Rosenwald A, Wang Q, et al. (2005) Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas. Hum Pathol 36: 494-504.
19. Casas S, Ollila J, Aventin A, Vihinen M, Sierra J, et al. (2003) Changes in apoptosis-related pathways in acute myelocytic leukemia. Cancer Genet Cytogenet 146: 89-101.
20. Feo F, De Miglio MR, Simile MM, Muroni MR, Calvisi DF, et al. (2006) Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition. Biochim Biophys Acta 1765: 126-147.
21. Katayama Y, Sakai A, Okikawa Y, Oue N, Asaoku H, et al. (2004) Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells. Int J Oncol 25: 579-595.
22. Stepanova L, Finegold M, DeMayo F, Schmidt EV, Harper JW, (2000) The oncoprotein kinase chaperone CDC37 functions as an oncogene in mice and collaborates with both c-myc and cyclin D1 in transformation of multiple tissues. Mol Cell Biol 20: 4462-4473.
23. Gray PJ Jr, Stevenson MA, Calderwood SK, (2007) Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells. Cancer Res 67: 11942-11950.
24. Matei D, Satpathy M, Cao L, Lai YC, Nakshatri H, et al. (2007) The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells. J Biol Chem 282: 445-453.
25. Sidera K, Samiotaki M, Yfanti E, Panayotou G, Patsavoudi E, (2004) Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system. J Biol Chem 279: 45379-45388.
26. Eustace BK, Sakurai T, Stewart JK, Yimlamai D, Unger C, et al. (2004) Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat Cell Biol 6: 507-514.
27. Stellas D, Karameris A, Patsavoudi E, (2007) Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis. Clin Cancer Res 13: 1831-1838.
28. Sidera K, Gaitanou M, Stellas D, Matsas R, Patsavoudi E, (2008) A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2. J Biol Chem 283: 2031-2041.
29. Stellas D, El Hamidieh A, Patsavoudi E, (2010) Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits. BMC Cell Biol 11: 51.
30. Tsutsumi S, Neckers L, (2007) Extracellular heat shock protein 90: a role for a molecular chaperone in cell motility and cancer metastasis. Cancer Sci 98: 1536-1539.
31. Eustace BK, Jay DG, (2004) Extracellular roles for the molecular chaperone, hsp90. Cell Cycle 3: 1098-1100.
32. Sims JD, McCready J, Jay DG, (2011) Extracellular heat shock protein (Hsp)70 and Hsp90alpha assist in matrix metalloproteinase-2 activation and breast cancer cell migration and invasion. PLoS One 6: e18848.
33. Walsh N, Larkin A, Swan N, Conlon K, Dowling P, et al. (2011) RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation. Cancer Lett 306: 180-189.
34. Thomaidou D, Patsavoudi E, (1993) Identification of a novel neuron-specific surface antigen in the developing nervous system, by monoclonal antibody 4C5. Neuroscience 53: 813-827.
35. Patsavoudi E, Hurel C, Matsas R, (1991) Purification and characterization of neuron-specific surface antigen defined by monoclonal antibody BM88. J Neurochem 56: 782-788.
36. Meintanis S, Thomaidou D, Jessen KR, Mirsky R, Matsas R, (2001) The neuron-glia signal beta-neuregulin promotes Schwann cell motility via the MAPK pathway. Glia 34: 39-51.
37. Vaughan CK, Gohlke U, Sobott F, Good VM, Ali MM, et al. (2006) Structure of an Hsp90-Cdc37-Cdk4 complex. Mol Cell 23: 697-707.
38. Cheng CF, Sahu D, Tsen F, Zhao Z, Fan J, et al. (2011) A fragment of secreted Hsp90alpha carries properties that enable it to accelerate effectively both acute and diabetic wound healing in mice. J Clin Invest 121: 4348-4361.